MoneyWorks4Me

A minor change in the total revenue was seen in the September 2022 quarter. The total revenue for the quarter stood at Rs. 605.26 millions against Rs. 583.93 millions during year ago period.Net profit for the quarter ended September 2022 increased significantly by 58.61% to Rs. 104.11 millions from Rs. 65.64 millions.Operating profit surged to 140.22 millions from the corresponding previous quarter of 96.87 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 605.26 583.93 3.65 1211.23 1124.48 7.71 2260.97 1879.46 20.30
Other Income 11.21 2.85 293.33 14.34 11.07 29.54 33.36 43.93 -24.06
PBIDT 140.22 96.87 44.75 207.53 197.84 4.90 291.31 234.72 24.11
Interest 0.26 0.63 -58.73 0.40 1.68 -76.19 2.85 5.14 -44.55
PBDT 139.96 96.24 45.43 149.09 196.16 -24.00 288.46 229.58 25.65
Depreciation 2.04 2.28 -10.53 3.97 5.11 -22.31 15.26 10.86 40.52
PBT 137.92 93.96 46.79 145.12 191.05 -24.04 273.20 218.72 24.91
TAX 33.81 28.32 19.39 37.32 56.91 -34.42 77.32 48.14 60.61
Deferred Tax 1.43 -1.24 -215.32 -3.25 -1.11 192.79 0.00 0.00 0.00
PAT 104.11 65.64 58.61 107.80 134.14 -19.64 195.88 170.58 14.83
Equity 130.99 130.99 0.00 130.99 130.99 0.00 130.99 130.99 0.00
PBIDTM(%) 23.17 16.59 39.65 17.13 17.59 -2.62 12.88 12.49 3.17
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..